U.S. Online Retail and Ecommerce Stock News

AeroVironment (AVAV) just caught fresh attention after KeyBanc initiated coverage with an upbeat view on its role in defense technology and space, helping the stock climb even as recent earnings and guidance remained mixed. See our latest analysis for AeroVironment. The latest 1 day share price gain of 5.09 percent to 255.39 dollars caps a volatile few months. Recent contract wins in lasers, maritime robotics, and electronic warfare have offset earlier weakness, and the 1 year total...

Ryder System (R) has been climbing on a wave of upbeat Wall Street coverage, as several major firms express confidence in its outlook, even while recent boardroom changes remain more of a background governance story. See our latest analysis for Ryder System. Those upbeat calls appear to be landing with investors, with Ryder’s share price at $195.18 after a 16.01 percent 30 day share price return and a powerful 253.31 percent five year total shareholder return, suggesting momentum is still...

Earlier this month, Array Technologies reported third-quarter 2025 earnings and revenue ahead of market expectations and confirmed the acquisition of APA Solar, aimed at enhancing access to tax credits and operational efficiencies. This combination of outperformance and an expansion into engineered foundation and fixed-tilt solutions could meaningfully reshape how investors assess Array’s long-term margin and growth potential. We’ll now examine how Array’s stronger-than-expected quarter and...

If you are wondering whether Indivior is still worth buying after a huge run up, you are not alone. This article will walk through what the current price really implies. The stock has climbed about 3.0% over the last week, 11.3% over the past month, and an eye catching 191.6% year to date, with a 204.0% gain over the last year underscoring how quickly sentiment has shifted. Investors have been reacting to a stream of updates around Indivior's positioning in treatments for opioid use disorder...

Adaptive Biotechnologies (ADPT) just signed two non exclusive deals with Pfizer that put its T cell receptor discovery platform and massive antigen mapping dataset at the center of Pfizer’s rheumatoid arthritis and AI driven drug discovery work. See our latest analysis for Adaptive Biotechnologies. The Pfizer collaborations come on top of an already sharp re rating, with a roughly 181 percent year to date share price return and a 175 percent one year total shareholder return suggesting...

Nexa Resources S.A. recently completed the sale of ten Exclusive Prospecting Licenses in Namibia, transferring all related rights to Midnab Resources as part of its Otavi and Namibia North projects. This divestment marks a further step in Nexa’s portfolio optimization, signaling a clearer focus on capital discipline and return-generating assets. We’ll now examine how this portfolio optimization effort, centered on exiting Namibian exploration licenses, shapes Nexa’s broader investment...

Stanley Black & Decker (SWK) has quietly turned a corner, with the stock up about 3% in a day and roughly 14% over the past month, drawing fresh attention to its recovery story. See our latest analysis for Stanley Black & Decker. That recent bounce sits against a more mixed backdrop, with the latest share price at $75.24, a negative year to date share price return, but a modestly improving one year total shareholder return. This suggests sentiment is cautiously turning rather than roaring...

Wendy's (WEN) shares have quietly drifted lower this year, leaving the stock trading near single digits even as the business continues to grow revenue and earnings at a modest clip. See our latest analysis for Wendy's. That slow grind lower has left Wendy's share price at $8.29, with a steep year to date share price return of around minus 49 percent and a three year total shareholder return near minus 58 percent, signaling momentum that is clearly fading despite steady fundamental growth. If...

Albany International has reported that its Albany Engineered Composites segment achieved U.S. Department of War Cybersecurity Maturity Model Certification Level 2, confirming its eligibility as a supplier for sensitive fixed-wing, hypersonic, missile, and rotorcraft programs. This certification deepens Albany’s role in the national security supply chain, potentially reinforcing its defense-related composites business as a core long-term revenue pillar. We’ll now examine how Albany’s new CMMC...

XPO, Inc. is shaking up its boardroom, with founder Brad Jacobs stepping down as Executive Chairman and CEO Mario Harik assuming the Chairman role. This shift puts leadership focus and strategic continuity squarely in the spotlight for investors. See our latest analysis for XPO. The leadership reshuffle lands at a time when XPO’s 1 month share price return of 6.60 percent and year to date share price return of 6.63 percent suggest moderate but positive momentum. A three year total shareholder...

Five9 (FIVN) has quietly slipped around 22% over the past 3 months and is down about 52% in the past year, even as revenue and earnings keep grinding higher in the background. See our latest analysis for Five9. That pattern fits a stock where sentiment is still cooling, with a weak year to date share price return and heavy three year and five year total shareholder return losses, despite recent operational progress. If Five9’s slide has you reassessing your exposure to software and AI, it...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Advance Auto Parts, Inc. ( NYSE:AAP ) has announced that it will pay a dividend of $0.25 per share on the 23rd of...

Simmons First National recently reported quarterly revenue of US$236.3 million, a 12.7% year-on-year increase that surpassed analyst expectations by 1.2%, although earnings per share only matched forecasts and tangible book value per share fell short. This mix of strong top-line momentum and softer profitability metrics highlights how the bank is capturing higher revenues while still contending with margin and balance-sheet pressures common across regional lenders. We’ll now examine how this...

In December 2025, United Rentals announced it had rolled out Manual Assist AI across its operations, a web-based tool built with Amazon Web Services that gives more than 4,000 monthly users AI-powered access to thousands of equipment manuals and diagnostics. This enterprise-wide AI adoption highlights how United Rentals is using cloud-based generative tools to speed repairs, reduce downtime, and keep more rental equipment productive on customer jobsites. Next, we’ll explore how this...

The FDA approval of MYQORZO for obstructive hypertrophic cardiomyopathy has initiated Royalty Pharma (RPRX)'s royalty stream and repayment terms, a material catalyst that strengthens its long-term cash flow profile. See our latest analysis for Royalty Pharma. This latest FDA milestone lands on top of a strong run, with the share price up 50.68 percent year to date and a 12 month total shareholder return of 57.78 percent. This suggests momentum is building as investors reassess Royalty...

Equinix (EQIX) is back on traders' screens after fresh earnings revisions and a friendlier rate backdrop pushed data center REITs higher, tying its story even closer to the AI infrastructure build out. See our latest analysis for Equinix. Despite the upbeat earnings revisions and AI driven tailwinds, Equinix’s share price return has stayed under pressure with a roughly 19.7 percent year to date decline, even though its three year total shareholder return of about 22.7 percent still signals...

In recent days, OceanFirst Financial has attracted increased attention after DA Davidson, Keefe, Bruyette & Woods, and Raymond James all raised their ratings on the bank to more positive levels. This rare clustering of upgrades from multiple research houses highlights a growing conviction in OceanFirst’s business trajectory and risk profile among professional analysts. We’ll now examine how this wave of analyst upgrades might reshape OceanFirst Financial’s investment narrative, especially...

Plains All American Pipeline has moved to safeguard its payout by selling its Canadian natural gas liquids assets for US$3.80 billion and acquiring the Epic Crude Oil Pipeline, aiming for about 85% of earnings from more stable sources and a leverage ratio around the midpoint of its 3.5 times target range. This reshaping of the portfolio, combined with a comfortably covered high-yield payout and an ambition for roughly 10% annual dividend growth until reaching its target coverage, signals a...

Distribution Solutions Group (DSGR) just secured a larger, extended credit facility running through 2030, increasing both its term debt and revolving credit, and effectively giving management more flexibility to fund future growth initiatives. See our latest analysis for Distribution Solutions Group. Even with the expanded credit facility hinting at bolder growth plans, the stock has been under pressure, with a weak year to date share price return but still a solid three year total...

Keurig Dr Pepper (KDP) has been grinding out steady growth, but the stock’s recent slip this year contrasts with improving revenue and net income trends, raising fresh questions about how investors are valuing its long term cash generation. See our latest analysis for Keurig Dr Pepper. At around $28.24, Keurig Dr Pepper’s recent share price return has been weak year to date, but the 90 day share price return of 7.58 percent hints that sentiment toward its cash generation story may be...

Flowserve Corporation ( NYSE:FLS ) stock is about to trade ex-dividend in 2 days. The ex-dividend date occurs one day...

Avis Budget Group recently reported that it has not increased available rental days over the past two years, while its return on invested capital has fallen and debt-fueled cash burn has intensified, raising fresh concern about demand and capital efficiency. Taken together, these trends point to a business struggling to find profitable growth opportunities in a potentially saturated market, with balance sheet pressure heightening the risk profile for investors. We’ll now examine how Avis...

How Quest Diagnostics Stock Has Been Performing Quest Diagnostics (DGX) has quietly outpaced many healthcare peers over the past year, with the stock up about 17% and a solid 64% gain over the past 5 years. That kind of long term compounding, backed by steady revenue and net income growth, makes Quest interesting for investors who prefer durable cash flows rather than story driven momentum. See our latest analysis for Quest Diagnostics. In the near term, the 1 month share price return of...